Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle.
The antibody and cell mediated immune responses induced by BHV-1 were analysed in cattle after vaccination and challenge exposure to the virulent strain LA of BHV-1. Animals were vaccinated intramuscularly (IM) with inactivated virus vaccines against BHV-1 containing either a water in mineral oil adjuvant (W/O), a water in mineral oil adjuvant plus Avridine (W/O+Avridine) or sulfolipo-cyclodextrin in squalane in-water emulsion (SL-CD/S/W). No significant differences were registered in the antibody response induced by the three evaluated vaccines. However, the BHV-1 specific cell-mediated immunite response was stronger and appeared earlier when SL-CD/S/W was included in the formulation. The efficacy of the vaccines was also evaluated after intranasal challenge of the calves with a virulent BHV-1 LA strain. Animals vaccinated with SL-CD/S/W had reduced virus excretion and clinical symptoms compared with the mock-vaccinated animals. Comparison of levels of BHV-1 specific IgG2 and IgG1 with virus shedding revealed that, regardless of the adjuvant administered, animals showing BHV-1 specific IgG2/IgG1 ratios higher than 1 were those with a significant lower number of individuals shedding virus. Additionally, animals vaccinated with SL-CD/S/W presented no post-vaccinal reactions. These factors, combined with the higher efficacy and the ease of manipulation of the biodegradable oil, makes the vaccine formulated with this new adjuvant an important contribution for the veterinary vaccines industry.
Romera
S A
SA
Instituto de Virología, Centro de Investigaciones en Ciencias Veterinarias (CICV), Instituto Nacional de Tecnología Agropecuaria (INTA), Castelar, 1708 Morón, Argentina.
Hilgers
L A
LA
Puntel
M
M
Zamorano
P I
PI
Alcon
V L
VL
Dus Santos
M J
MJ
Blanco Viera
J
J
Borca
M V
MV
Sadir
A M
AM
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects; D002417:Cattle; D003505:Cyclodextrins / Q000008:administration & dosage* / Q000276:immunology; D004655:Emulsions / Q000008:administration & dosage; D007242:Herpesvirus 1, Bovine / Q000276:immunology*; D007111:Immunity, Cellular / Q000187:drug effects; D007074:Immunoglobulin G / Q000032:analysis; D007241:Infectious Bovine Rhinotracheitis / Q000517:prevention & control*; D008213:Lymphocyte Activation / Q000276:immunology; D008899:Mineral Oil / Q000008:administration & dosage; D009500:Neutralization Tests; D013185:Squalene / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000276:immunology; D015164:Vaccines, Inactivated / Q000008:administration & dosage* / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000276:immunology; D017201:Virus Shedding / Q000276:immunology; D014867:Water / Q000008:administration & dosage
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D003505:Cyclodextrins; D004655:Emulsions; D007074:Immunoglobulin G; D015164:Vaccines, Inactivated; D014765:Viral Vaccines; C118681:sulfolipo-cyclodextrin; D014867:Water; D013185:Squalene; D008899:Mineral Oil; C019556:squalane